| scholarly article | Q13442814 |
| P356 | DOI | 10.1309/AJCP4Q0NSDHWIZGU |
| P698 | PubMed publication ID | 25511151 |
| P50 | author | Kathleen M. Schmeler | Q89994549 |
| Philip E. Castle | Q90438073 | ||
| P2093 | author name string | Thomas C Wright | |
| Mark H Stoler | |||
| Thomas E Davis | |||
| Alex Ferenczy | |||
| Daron G Ferris | |||
| Mark H Einstein | |||
| Ashlyn H Savage | |||
| Katherine M Smith | |||
| Jermaine E Gray | |||
| P2860 | cites work | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer | Q24607403 |
| The impact and cost of scaling up GeneXpert MTB/RIF in South Africa | Q28484044 | ||
| Clinical evaluation of the cartridge-based GeneXpert human papillomavirus assay in women referred for colposcopy | Q30412457 | ||
| The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays | Q30442823 | ||
| Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible | Q33951232 | ||
| Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study | Q34834113 | ||
| Clinical validation of the cobas 4800 HPV test for cervical screening purposes. | Q35530540 | ||
| The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women | Q36615291 | ||
| Human papillomavirus genotype specificity of hybrid capture 2 | Q36845399 | ||
| Effect of cervical cytologic status on the association between human papillomavirus type 16 DNA load and the risk of cervical intraepithelial neoplasia grade 3. | Q37443985 | ||
| Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older | Q37461977 | ||
| High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease | Q37656990 | ||
| 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors | Q38091972 | ||
| The Papanicolaou test for cervical cancer detection. A triumph and a tragedy | Q38597626 | ||
| High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women | Q40483381 | ||
| Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33-positive women with normal cytology | Q43566239 | ||
| High-risk human papillomavirus DNA load in a population-based cervical screening cohort in relation to the detection of high-grade cervical intraepithelial neoplasia and cervical cancer | Q43716837 | ||
| Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study | Q45206974 | ||
| Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study | Q47779516 | ||
| Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. | Q53340958 | ||
| Viral load of human papillomavirus and risk of CIN3 or cervical cancer. | Q53388308 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colposcopy | Q912741 |
| P304 | page(s) | 126-133 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
| P1476 | title | Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population | |
| P478 | volume | 143 |
| Q40117003 | Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay. |
| Q41435062 | Attitude to Human Papillomavirus Deoxyribonucleic Acid-Based Cervical Cancer Screening in Antenatal Care in Nigeria: A Qualitative Study |
| Q33891238 | Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach |
| Q53176728 | Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid. |
| Q37040460 | Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens |
| Q46902171 | HPV-FASTER: broadening the scope for prevention of HPV-related cancer |
| Q90805909 | HPV-based cervical screening: Rationale, expectations and future perspectives of the new Dutch screening programme |
| Q64936012 | Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis. |
| Q37218644 | Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests) |
| Q55259586 | Performance of the Xpert HPV assay in women attending for cervical screening. |
| Q40045282 | Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected Women |
| Q58800228 | Protocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda |
| Q64265787 | Synergistically enhanced colorimetric molecular detection using smart cup: a case for instrument-free HPV-associated cancer screening |
| Q47599029 | Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women |
Search more.